Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Fei Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5446-9854; OpenAlex author ID A5058087359. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer. Co-author DOI 10.1515/biol-2022-0538↗
  2. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer]. Co-author PMID 24721346↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongqiang Hua · 1 shared paper, 2023 · strength 0.18
  2. Feng Wang · 1 shared paper, 2023 · strength 0.18
  3. Yongfeng Hui · 1 shared paper, 2023 · strength 0.18
  4. Weiwei Sheng · 1 shared paper, 2014 · strength 0.06
  5. Ming Dong · 1 shared paper, 2014 · strength 0.06
  6. Jianping Zhou · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.